Foundational clinical and mechanistic literature (20212022) The SURPASS-1 through SURPASS-5 trials, published across NEJM and The Lancet in 20212022, characterised tirzepatide's glycaemic and weight outcomes versus placebo, semaglutide, insulin degludec, and insulin glargine at doses up to 15 mg once weekly [9]
PMID 34791642.
36 Simmons, K
Thus, in the pancreas, the precursor is processed by PC2 to generate glucagon and glicentin-related pancreatic polypeptide (GRPP), whereas in L cells PC1/3 processing results in the production of glicentin, oxyntomodulin (OXM), GLP-1, and GLP-2
Quality of compounded semaglutide
cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects